New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement
IBRN
Passive ETF
NYSE

iShares Neuroscience and Healthcare ETF

This ETF provides exposure to Equities Read more

Passive ETF
Last update 3/13/2026 at 1:30 PM
Live
Closed
This fund is part of
Healthcare Technology
-0.41%
Last Price
$31.00
% Change
-1.73%
1W flows
-
1m flows
-
AuM
$5M
E/R
0.47%
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios
Advertisement
Compare IBRN with
Another ETF ›

Trading data

Last sale
3/13/2026 at 1:30 PM
$31.00
Previous close
$31.55
Consolidated volume
03/12/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

IBRN performance and flow charts

Performance

-2.00.02.04.0%Feb 12Feb 17Feb 19Feb 23Feb 26Mar 2Mar 4Mar 6Mar 10Mar 12

Flows

0

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows

Data as of March 12, 2026
1M3MYTD1Y3Y5Y
Perf.-0.41%-1.92%-2.32%+34.51%+35.71%
Flows-----$1M-
Data as of March 12, 2026

Volatility and drawdown

3M1Y3Y5Y
Volatility+25.30%+28.21%+24.21%
Max drawdown
-8.08%-23.45%-34.98%
Max drawdown duration
49d148d338dN/A
Time to recover
N/A127d191dN/A

Replication quality

Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free

Exposure

Data as of January 31, 2026

Countries

USA
70.96%
Ireland
7.75%
Other
21.29%

Sectors

Health Care
75.49%
Other
24.51%

Diversification

Total weight of top 15 holdings out of 59

57.3%

Top 15 Holdings

US74006W2070
4.97%
AXSOME THERA CMN STK
4.86%
ALKERMES
4.63%
SCHOLAR ROCK HOLDING CORP
3.91%
PTC THERAPEUTI/D
3.88%
BIOGEN INC
3.81%
US04016X1019
3.68%
ACADIA PHARMACEUTICALS
3.67%
DENALI THERAPEUTICS INC
3.64%
XENON PHARMACEUTICALS
3.64%
CATALYST PHARMACEUTICALS INC
3.53%
NEUROCRINE BIOSCIENCES
3.48%
SUPERNUS PHARMACEUTICALS
3.46%
US1523091007
3.1%
SK BIOPHARMACEUTICALS CO LTD
3.05%

Characteristics

The iShares Neuroscience and Healthcare ETF is built to track the NYSE FactSet Global Neuro Biopharma and MedTech Net Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly).

This share class generates a stream of income by distributing dividends.

Management strategyPassive
ProvideriShares
N° of holdings59
Replication methodDirect (Physical)
Asset classEquities
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateAugust 24, 2022
ESGNo

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

Advertisement
Advertisement
Advertisement
Frequently asked questions about IBRN

What type of ETF is IBRN?

IBRN is a Passive ETF that provides exposure to Equity assets. It is managed by iShares.

What index does IBRN track?

IBRN tracks the NYSE FactSet Global Neuro Biopharma and MedTech Net Index - USD, aiming to replicate its performance through optimized sampling.

What does IBRN invest in?

This ETF provides exposure to Equities. It is part of the segment: Healthcare Technology.

What is the expense ratio of IBRN?

The total expense ratio (TER) of IBRN is 0.47%, representing the annual fee charged by the fund manager.

When was IBRN launched?

IBRN was launched on August 24, 2022, marking its entry into the ETF market.

Who is the issuer of IBRN?

IBRN is issued by iShares.

What is the AUM of IBRN?

As of March 12, 2026, IBRN manages $4.73 M, reflecting the total assets held in the fund.

How has IBRN performed recently?

As of March 12, 2026, IBRN delivered a return of -0.41% over the past month (1M performance), -1.92% over the past three months (3M), and -2.32% year-to-date (YTD).

Does IBRN pay dividends?

As of March 12, 2026, IBRN has a trailing 12-month distribution yield of 1.01%.

How many holdings are in IBRN

As of January 31, 2026, IBRN holds 59 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is IBRN?

As of January 31, 2026, IBRN holds 59 securities, with 57.3% of its assets concentrated in its top 15 holdings.

What are the top holdings of IBRN?

As of January 31, 2026, IBRN holds a portfolio of 59 underlyings, with its largest positions including US74006W2070, AXSOME THERA CMN STK and ALKERMES. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does IBRN invest in?

As of January 31, 2026, IBRN has its largest geographic exposures in USA and Ireland.

What sectors or themes does IBRN focus on?

As of January 31, 2026, IBRN is primarily exposed to Health Care.

Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring

Asset TV

The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring

Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.

Asset TV
By Asset TV · March 6, 2026
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)

What’sTheFund

What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)

Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).

NYSE logo
By NYSE · March 6, 2026
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)

What’sTheFund

What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)

Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).

NYSE logo
By NYSE · March 6, 2026
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)

What’sTheFund

What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)

Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).

NYSE logo
By NYSE · March 6, 2026

Browse all educational columns

Advertisement
ETF Comparison Tool

Have you tried our ETF Compare tool?

Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.